With the Welch Allyn RetinaVue care delivery model, Baxter provides
board-certified, state-licensed eye specialists in all 50 states who
can detect can detect up to 30 vision conditions including
vision threatening pathologies including:
Intercepting patients during routine primary care office visits with a teleretinal program like the RetinaVue care delivery model can help providers achieve up to 90% documented compliance with diabetic retinal exams in just 12 months.1
That means potential financial incentives from quality programs — and more importantly, the opportunity to help save more patients’ vision.
This helps clinicians identify serious eye disease early so they can develop timely treatment decisions and care plans that support preserving patients’ vision.
With a single exam, it offers a simple, fast way to help elevate care, close care gaps, and improve outcomes for patients living with diabetes in point-of-care settings.
Learn how your healthcare organization can help preserve vision in patients living with diabetes by connecting with a Baxter Vision consultant.
Rx Only: For safe and proper use of the products mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.
All clinical interpretations are performed by a licensed ophthalmologist.
